← Back to Search

Quadratus Lumborum Blocks for Postoperative Pain

Phase 4
Waitlist Available
Led By Randa J Jalloul, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours after anesthesia
Awards & highlights

Study Summary

This trial will compare two types of pain management for patients undergoing laparoscopic or robotic hysterectomy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours after anesthesia
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours after anesthesia for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Emotional state as assessed by the Quality of Recovery (QOR-40) validated questionnaire
Pain as assessed by the Quality of Recovery (QOR-40) validated questionnaire
Physical comfort as assessed by the Quality of Recovery (QOR-40) validated questionnaire
+2 more
Secondary outcome measures
Amount of oral morphine consumed measured in morphine milliequivalents (OME)
Pain at rest as assessed by the visual analog scale

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: QL BlockExperimental Treatment2 Interventions
Group II: Local Anesthesia at incision siteActive Control2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
QL
2022
Completed Phase 4
~80
Sham Local
2022
Completed Phase 4
~80

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
905 Previous Clinical Trials
321,034 Total Patients Enrolled
5 Trials studying Postoperative Pain
657 Patients Enrolled for Postoperative Pain
Randa J Jalloul, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
150 Total Patients Enrolled

Media Library

Postoperative Pain Clinical Trial 2023: Laparoscopic Hysterectomy Highlights & Side Effects. Trial Name: NCT05480111 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the FDA accorded authorization to QL?

"The safety of QL has been extensively studied and is approved, thus receiving a score of 3."

Answered by AI

Are there any vacancies in the current clinical trial available to individuals seeking treatment?

"The clinicaltrials.gov website indicates this trial is no longer recruiting, with an initial posting date of July 27th 2022 and a last update on the same day. However, 483 other trials are currently open to participation."

Answered by AI

Who else is applying?

What state do they live in?
British Columbia
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy
Randa Jalloul 2022. "The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05480111.
~28 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top